Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

There are few data regarding disparities in overall survival (OS) between Asian and white men with metastatic castration-resistant prostate cancer (mCRPC). We compared OS of Asian and white mCRPC men treated in phase III clinical trials with docetaxel and prednisone (DP) or a DP-containing regimen....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JNCI Cancer Spectr
Main Authors: Halabi, Susan, Dutta, Sandipan, Tangen, Catherine M, Rosenthal, Mark, Petrylak, Daniel P, Thompson, Ian M, Chi, Kim N, De Bono, Johann S, Araujo, John C, Logothetis, Christopher, Eisenberger, Mario A, Quinn, David I, Fizazi, Karim, Morris, Michael J, Higano, Celestia S, Tannock, Ian F, Small, Eric J, Kelly, William Kevin
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Brief Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7190204/
https://ncbi.nlm.nih.gov/pubmed/32368717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa003
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki